
In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Larry Brown, Sc.D., chief scientific officer at Noveome Biotherapeutics, to discuss ST266, a first-of-its-kind secretome therapy. This cell-free biologic is essentially a collection of proteins and other factors produced by amnion-derived epithelial cells and is being studied for necrotizing enterocolitis. Brown explains the story behind this novel therapy, the GMP manufacturing process Noveome developed to produce it,...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

Digitalizing The Biopharma Ecosystem With Kat Kozyrytska

Modulating Multispecific Manufacturability With AP Biosciences’ JJ You, Ph.D.

The Facility Master Planning Playbook With Herman Bozenhardt

The Editors’ Roundtable: A Midyear Look At The 2026 Life Sciences Industry
Free AI-powered recaps of Better Biopharma and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.